AbbVie manufactures some of the most widely prescribed and expensive medications in the United States, including Humira, Skyrizi, Rinvoq, and Venclexta. For patients without adequate insurance, these drugs can cost $5,000 to $15,000 per month at retail. The AbbVie Patient Assistance program, known as myAbbVie Assist, provides qualifying patients with their medications at no cost. This guide explains how the program works, who is eligible, and how to apply.
Overview of AbbVie Patient Assistance
The AbbVie Patient Assistance program (myAbbVie Assist) is the company’s initiative to help uninsured and underinsured patients access AbbVie medications. The program covers a broad portfolio of drugs used in immunology, oncology, hepatitis C, and other therapeutic areas. Approved patients receive their medications free of charge, delivered directly to their home or prescriber’s office.
AbbVie has provided billions of dollars in free medications through this program. The company reports that myAbbVie Assist has helped hundreds of thousands of patients since its launch. The program is one of the largest manufacturer assistance initiatives in the pharmaceutical industry, reflecting the high cost and clinical importance of AbbVie’s drug portfolio.
Medications Covered
The myAbbVie Assist program covers a wide range of products. Humira (adalimumab) for autoimmune conditions including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriasis, and more. Skyrizi (risankizumab) for plaque psoriasis and psoriatic arthritis. Rinvoq (upadacitinib) for rheumatoid arthritis, atopic dermatitis, and ulcerative colitis. Venclexta (venetoclax) for chronic lymphocytic leukemia. Imbruvica (ibrutinib) for blood cancers. Viekira Pak and Mavyret for hepatitis C.
Each medication may have slightly different eligibility criteria or application procedures within the overarching myAbbVie Assist framework. Visit AbbVie.com or call 1-800-222-6885 for the most current list of covered medications and specific program details.
Eligibility Requirements
To qualify for AbbVie Patient Assistance, you must meet the following general criteria. You must be a U.S. resident or citizen. You must have a valid prescription from a licensed U.S. healthcare provider. You must not have insurance coverage that pays for the AbbVie medication, including Medicare Part D, Medicaid, VA benefits, Tricare, or commercial insurance that covers the drug.
Income eligibility varies by medication but generally requires household income at or below 400% to 600% of the Federal Poverty Level. For 2026, 400% FPL is approximately $62,400 for an individual, while 600% FPL is approximately $93,600. Some oncology products have higher income thresholds or fewer restrictions, reflecting the critical nature of cancer treatment. AbbVie evaluates applications on a case-by-case basis, and hardship exceptions may be available.
How to Apply
The application begins with your healthcare provider. Your prescriber downloads the enrollment form from the AbbVie website or the specific drug’s patient support hub (such as Humira Complete, Skyrizi Complete, or Rinvoq Complete). The form requires the prescriber’s information, your diagnosis and prescribed medication, and your financial details.
You will need to submit proof of income, typically your most recent federal tax return or two recent pay stubs. A copy of your government-issued ID and a signed patient authorization form are also required. Your prescriber faxes or mails the completed package to myAbbVie Assist. Processing takes approximately 2 to 4 weeks.
Once approved, you receive medication shipments on a regular schedule aligned with your dosing regimen. For injectable biologics like Humira, medications are shipped in temperature-controlled packaging directly to your home. Renewal is required annually with updated financial documentation.
AbbVie Copay Assistance for Insured Patients
If you have commercial insurance that covers an AbbVie medication but your copay is high, AbbVie offers copay assistance programs separate from the PAP. The Humira Complete savings card, for example, can reduce your copay to as little as $5 per month. Skyrizi and Rinvoq offer similar copay programs for commercially insured patients.
These copay cards cannot be used by patients with government insurance (Medicare, Medicaid, Tricare, VA). For Medicare beneficiaries, Medicare Extra Help is the primary avenue for reducing Part D copays. The copay assistance programs have annual benefit caps that vary by product, so review the terms for your specific medication.
Navigating the Humira Biosimilar Landscape
With the entry of adalimumab biosimilars such as Hadlima, Hyrimoz, Cyltezo, and Amjevita into the U.S. market, patients previously dependent on Humira have more options. Biosimilars are typically priced 15% to 40% below the reference product. If you are currently using Humira through the AbbVie PAP and biosimilars become a more affordable option through your insurance or a discount program, discuss the switch with your doctor.
AbbVie has responded to biosimilar competition by expanding its copay assistance and patient support services. The myAbbVie Assist program continues to cover Humira, and the company has indicated that the PAP will remain available as long as patients need it. For broader comparisons of drug savings options, visit our healthcare costs guide.
Alternative Savings Options
If you do not qualify for the AbbVie PAP, other resources may help. 340B pharmacies offer discounted pricing for patients at qualifying healthcare facilities. Prescription discount cards provide modest savings on some brand-name drugs, though the discounts on specialty biologics are typically limited. State Pharmaceutical Assistance Programs may cover copays or provide supplemental drug coverage depending on your state.
Nonprofit organizations such as the Patient Access Network Foundation (PAN), the HealthWell Foundation, and the Leukemia & Lymphoma Society also offer copay assistance for specific disease categories. These organizations are available to patients with insurance, including Medicare beneficiaries, unlike manufacturer copay cards.
Frequently Asked Questions
Can Medicare patients use AbbVie Patient Assistance?
Medicare Part D beneficiaries are generally ineligible for the myAbbVie Assist PAP. However, Medicare patients who do not have Part D or a Medicare Advantage plan with drug coverage may qualify. Contact myAbbVie Assist at 1-800-222-6885 to discuss your specific coverage situation.
How long does it take to receive medication after approval?
After approval, your first shipment typically arrives within 5 to 10 business days. Subsequent shipments are scheduled based on your dosing frequency. For urgent situations, AbbVie may be able to provide a temporary bridge supply. Ask your prescriber or call the patient support line.
Does the program cover all AbbVie medications?
The AbbVie Patient Assistance program covers most AbbVie products, but not every medication in the portfolio may be included at all times. The covered medication list is updated periodically. Call 1-800-222-6885 or visit AbbVie.com for the current list.
What happens if I gain insurance while enrolled?
If you obtain insurance that covers your AbbVie medication during your enrollment period, you must notify myAbbVie Assist. You will be transitioned off the PAP and may be eligible for copay assistance if your new coverage is commercial insurance. Continuing to use the PAP while insured violates program terms.
Is there a limit on how long I can use the program?
There is no lifetime limit on participation. As long as you continue to meet eligibility requirements and reapply annually with updated documentation, you can receive medications through myAbbVie Assist indefinitely.
Access the Medications You Need
AbbVie’s specialty medications treat serious, chronic conditions that require consistent treatment. The myAbbVie Assist program ensures that cost is not a barrier to access for eligible patients. Talk to your healthcare provider about starting the application, or call 1-800-222-6885 for direct assistance. For a complete picture of prescription savings options, explore our healthcare costs guide and related programs like the Rinvoq Patient Assistance Program.